Tegaserod maleate exerts anti-tumor effects on prostate cancer via repressing sonic hedgehog signaling pathway

Abstract Prostate cancer (PCa) is a highly common type of malignancy and affects millions of men in the world since it is easy to recur or emerge therapy resistance. Therefore, it is urgent to find novel treatments for PCa patients. In the current study, we found that tegaserod maleate (TM), an FDA-...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Maoping Cai, Shengdong Ge, Yaying Hong, Yao Chen, Yang-Zi Ren, Dacai Zhong, Mingkun Chen, Yuan Liu, Zhe-Sheng Chen, Ninghan Feng, Zhanghui Chen, Shan-Chao Zhao
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2025-01-01
Saila:	Molecular Medicine
Gaiak:	Prostate cancer (PCa) Tegaserod maleate (TM) Sonic hedgehog (SHH) signaling GLI2 Treatment
Sarrera elektronikoa:	https://doi.org/10.1186/s10020-025-01080-1
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!